EC Number |
Inhibitors |
Structure |
---|
1.14.14.86 | (1E)-1-[4-(4-butyl-1H-1,2,3-triazol-1-yl)phenyl]-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol |
- |
|
1.14.14.86 | (1E,3S)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol |
i.e. uniconazole |
|
1.14.14.86 | (2R,3R)-paclobutrazol |
0.0045 mM, 50% inhibition |
|
1.14.14.86 | (2R,3R)-paclobutrazol |
- |
|
1.14.14.86 | (2S,3S)-paclobutrazol |
0.00025 mM, 50% inhibition |
|
1.14.14.86 | (2S,3S)-paclobutrazol |
- |
|
1.14.14.86 | (5E)-6-tert-butyl-5-[(4-chlorophenyl)methylidene]-5,6-dihydro-8H-[1,2,4]triazolo[5,1-c][1,4]oxazine |
- |
|
1.14.14.86 | (5E)-6-tert-butyl-5-[(4-nitrophenyl)methylidene]-5,6-dihydro-8H-[1,2,4]triazolo[5,1-c][1,4]oxazine |
- |
|
1.14.14.86 | (E)-2-(2-((1-(4-(3-hydroxy-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-1-yl)phenyl)-1H-1,2,3-triazol-4-yl)methoxy)ethoxy)ethyl 4-methylbenzenesulfonate |
i.e. abscinazole-E1, orUT1-E2Ts, or Abz-E1, a specific potent inhibitor of ABA 8'-hydroxylase, EC 1.14.13.93, but a weak inhibitor of CYP701A, both in vitro and in vivo |
|
1.14.14.86 | abscinazole-F1 |
- |
|